← Back to Search

Taxane

Tesetaxel once every 3 weeks for Breast Cancer

Phase 2
Waitlist Available
Led By Andrew D Seidman, MD
Research Sponsored by Genta Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months from date of first dose of study medication for last patient enrolled
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing tesetaxel, an oral medication, to see if it can effectively treat patients with metastatic breast cancer. Tesetaxel works by stopping cancer cells from dividing and growing.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months from date of first dose of study medication for last patient enrolled
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months from date of first dose of study medication for last patient enrolled for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Response rate (revised RECIST)
Secondary study objectives
Adverse events
Disease control rate
Durable response rate
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Tesetaxel once weeklyExperimental Treatment1 Intervention
Tesetaxel 15 mg/m2 orally once every 7 days for 3 consecutive weeks in a 28-day cycle for up to 12 months
Group II: Tesetaxel once every 3 weeksExperimental Treatment1 Intervention
Tesetaxel 27 mg/m2 orally once every 21 days for up to 12 months

Find a Location

Who is running the clinical trial?

Genta IncorporatedLead Sponsor
30 Previous Clinical Trials
1,589 Total Patients Enrolled
Andrew D Seidman, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
213 Total Patients Enrolled
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top